
About us
The International Centre for Cancer Vaccine Science (ICCVS) has been established in 2017 as a joint unit of the University of Gdańsk (UG) and the University of Edinburgh (UoE) within a project carried out within the International Research Agendas Programme of the Foundation for Polish Science and the European Union under the European Regional Development Fund (ERDF).
The project “International Centre for Cancer Vaccine Science” has been supported with 42 122 280 PLN from ERDF for 2017-2023. The aim of the project has been comprehensive research into immunotherapies that could lead to the creation of personalized therapeutic cancer vaccines, followed by their commercialization and implementation into clinical practice.
Meet ICCVS
Meet the people and ideas driving research at our Centre

ICCVS as the only Polish team highlighted in the #Science4EU: Scientists in Action Campaign
‘Chemotherapy is less precise than biological therapies. It is like trying to kill a mosquito with a hammer – and the mosquito is sitting on your knee. You might miss it, or worse, hurt yourself’.
Prof. Natalia Marek-Trzonkowska, Director of the ICCVS
ICCVS in numbers
Research Groups
Projects
Scientific Publications
Our research groups pursue interdisciplinary research spanning immunology, cancer biology, biotechnology, bioinformatics, and related areas of biomedical science.
We carry out nationally and internationally funded projects, drawing on extensive experience in research management, collaboration and scientific excellence.
We contribute to the global scientific community through publications and collaborations with researchers worldwide.
Featured Projects
Discover the flagship research initiatives driving innovation and international collaboration at ICCVS
Join the Immune Memory & Cell Reprogramming Group and contribute to research on:
Translational Memory in Cytokine Tolerance supervised by Dr hab. Wojciech Siwek.
What’s new at ICCVS? Stay up to date with research news, achievements and activities from our Centre.













